Vanda Pharmaceuticals | VNDA - Ebitda

قیمت سهام
7.31
تغییر روزانه
-0.01 -0.14%
ماهیانه
-17.03%
سالیانه
67.28%
Q2 پیش بینی
7.02




Ebitda تغییر دادن تاریخ
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Agios Pharmaceuticals USD -115.49M 10.3M 2025-09
Akebia Therapeutics USD 14.03M 17.19M 2025-03
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
Anika Therapeutics USD 4.54M 3.67M 2025-12
Arrowhead Research USD 64.2M 223.53M 2025-09
AstraZeneca USD 5.23B 272M 2025-09
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -9.93M 24.99M 2025-09
Halozyme Therapeutics USD 21.9M 226.34M 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Insmed USD -314.19M 31.48M 2025-12
J&J USD 7.19B 2.32B 2025-12
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Ligand Pharmaceuticals USD 150.32M 129.42M 2025-09
Merck USD 8.39B 1.97B 2025-09
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Moderna USD -790M 582M 2025-12
Novartis USD 5.84B 235M 2025-09
Pfizer USD 6.08B 351M 2025-09
PTC Therapeutics USD 20.63M 53.74M 2025-09
Puma Biotechnology USD 729K 11.36M 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Takeda JPY 448.13B 173.98B 2025-12
Teva Pharmaceutical Industries USD 1.64B 243M 2025-12
Ultragenyx Pharmaceutical USD -156.79M 65.44M 2025-09
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12
Veracyte USD 42.31M 2.58M 2025-12